InVivo Therapeutics Holdings Corp. (NVIV) Social Stream
Invivo Therapeutics Holdings Corp (NVIV) Price Targets From Analysts
Use the tables below to see what analysts covering Invivo Therapeutics Holdings Corp think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 1 | $37.5 | $37.5 | $37.5 | $0.575 | 6421.74% |
Price Target Last Issued January 26, 2020
NVIV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Invivo Therapeutics Holdings Corp's number of analysts covering the stock is greater than nearly none of all US stocks.
- Invivo Therapeutics Holdings Corp's variance in analysts' estimates is less than almost 100% of all US stocks.
- NVIV has a higher upside potential (average analyst target price relative to current price) than 99.61% of Healthcare stocks.
- NVIV has a greater average analyst price target than 78.21% of stocks in the small market cap category.
Make investment decisions regarding NVIV using the data that counts. Try POWR Ratings for free.